QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lake-street-maintains-buy-on-orthopediatrics-lowers-price-target-to-34

Lake Street analyst Ben Haynor maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $37 to $34.

 stifel-maintains-buy-on-orthopediatrics-lowers-price-target-to-20

Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $32 to $20.

 jmp-securities-maintains-market-outperform-on-orthopediatrics-lowers-price-target-to-25

JMP Securities analyst David Turkaly maintains OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and lowers the price t...

 piper-sandler-maintains-overweight-on-orthopediatrics-lowers-price-target-to-22

Piper Sandler analyst Matt O'Brien maintains OrthoPediatrics (NASDAQ:KIDS) with a Overweight and lowers the price target...

 btig-maintains-buy-on-orthopediatrics-lowers-price-target-to-23

BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $39 to $23.

 orthopediatrics-lowers-fy2025-sales-guidance-from-237000m-242000m-to-233500m-234500m-vs-239440m-est

OrthoPediatrics (NASDAQ:KIDS) lowers FY2025 sales outlook from $237.000 million-$242.000 million to $233.500 million-$234.500 m...

 orthopediatrics-sees-q3-sales-61200m-vs-63590m-est

OrthoPediatrics (NASDAQ:KIDS) sees Q3 sales of $61.200 million vs $63.590 million analyst estimate.

 jmp-securities-maintains-market-outperform-on-orthopediatrics-lowers-price-target-to-35

JMP Securities analyst David Turkaly maintains OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and lowers the price t...

 btig-maintains-buy-on-orthopediatrics-lowers-price-target-to-39

BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $40 to $39.

 orthopediatrics-raises-fy2025-sales-guidance-from-23600m-24200m-to-23700m-24200m-vs-23931m-est

OrthoPediatrics (NASDAQ:KIDS) raises FY2025 sales outlook from $236.00 million-$242.00 million to $237.00 million-$242.00 milli...

 orthopediatrics-q2-adj-eps-011-beats-030-estimate-sales-6108m-miss-6140m-estimate

OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.3...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION